How many studies have been conducted on 2 3 Cyclic Nucleotide 3 Phosphodiesterase?

BiohacksAI has indexed 300 PubMed studies on 2 3 Cyclic Nucleotide 3 Phosphodiesterase. 10% of studies involve human subjects.

What are the main research areas for 2 3 Cyclic Nucleotide 3 Phosphodiesterase?

The primary research domains for 2 3 Cyclic Nucleotide 3 Phosphodiesterase are ⏳ Longevity & Aging, 🔬 Oncology, 🔥 Metabolic. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

2 3 Cyclic Nucleotide 3 Phosphodiesterase

A phosphodiesterase that specifically cleaves the 3'-phosphate linkage of 2',3'-cyclic nucleotides. It is found at high level in the cytoplasm of cells that form the MYELIN SHEATH.

300+ PubMed studies analyzed · Evidence Score: 44.3

Research Domains

2 3 Cyclic Nucleotide 3 Phosphodiesterase has been studied across 18 research domains including ⏳ Longevity & Aging, 🔬 Oncology, 🔥 Metabolic, ⚡ Energy & Fatigue, 🧠 Memory. The primary research focus is ⏳ Longevity & Aging with 10% of studies addressing this area.

Loading evidence profile...

This evidence profile for 2 3 Cyclic Nucleotide 3 Phosphodiesterase is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.